212 related articles for article (PubMed ID: 20551329)
21. Total synthesis of two novel subpicomolar sarco/endoplasmatic reticulum Ca2+-ATPase inhibitors designed by an analysis of the binding site of thapsigargin.
Søhoel H; Liljefors T; Ley SV; Oliver SF; Antonello A; Smith MD; Olsen CE; Isaacs JT; Christensen SB
J Med Chem; 2005 Nov; 48(22):7005-11. PubMed ID: 16250659
[TBL] [Abstract][Full Text] [Related]
22. Sarco-endoplasmic reticulum Ca2+ ATPase (SERCA) inhibitors identify a novel calcium pool in the central nervous system.
Watson WD; Facchina SL; Grimaldi M; Verma A
J Neurochem; 2003 Oct; 87(1):30-43. PubMed ID: 12969250
[TBL] [Abstract][Full Text] [Related]
23. Fragment Molecular Orbital Study of the Interaction between Sarco/Endoplasmic Reticulum Ca
Ishikawa T; Mizuta S; Kaneko O; Yahata K
J Phys Chem B; 2018 Aug; 122(33):7970-7977. PubMed ID: 30067362
[TBL] [Abstract][Full Text] [Related]
24. Sarco/Endoplasmic Reticulum Calcium ATPase Inhibitors: Beyond Anticancer Perspective.
Peterková L; Kmoníčková E; Ruml T; Rimpelová S
J Med Chem; 2020 Mar; 63(5):1937-1963. PubMed ID: 32030976
[TBL] [Abstract][Full Text] [Related]
25. Regulation of the Ca(2+)-ATPase by cholesterol: a specific or non-specific effect?
Autzen HE; Siuda I; Sonntag Y; Nissen P; Møller JV; Thøgersen L
Mol Membr Biol; 2015; 32(3):75-87. PubMed ID: 26260074
[TBL] [Abstract][Full Text] [Related]
26. Divergent synthesis of thapsigargin analogs.
Chu H; Dünstl G; Felding J; Baran PS
Bioorg Med Chem Lett; 2018 Sep; 28(16):2705-2707. PubMed ID: 29636219
[TBL] [Abstract][Full Text] [Related]
27. ACTA, a fluorescent analogue of thapsigargin, is a potent inhibitor and a conformational probe of skeletal muscle Ca2+-ATPase.
Procida K; Caspersen C; Kromann H; Christensen SB; Treiman M
FEBS Lett; 1998 Nov; 439(1-2):127-32. PubMed ID: 9849892
[TBL] [Abstract][Full Text] [Related]
28. Comparison of current docking tools for the simulation of inhibitor binding by the transmembrane domain of the sarco/endoplasmic reticulum calcium ATPase.
Lape M; Elam C; Paula S
Biophys Chem; 2010 Aug; 150(1-3):88-97. PubMed ID: 20167416
[TBL] [Abstract][Full Text] [Related]
29. Structural basis for relief of phospholamban-mediated inhibition of the sarcoplasmic reticulum Ca
Fernández-de Gortari E; Espinoza-Fonseca LM
J Biol Chem; 2018 Aug; 293(32):12405-12414. PubMed ID: 29934304
[TBL] [Abstract][Full Text] [Related]
30. Targeting oncogenic Notch signaling with SERCA inhibitors.
Pagliaro L; Marchesini M; Roti G
J Hematol Oncol; 2021 Jan; 14(1):8. PubMed ID: 33407740
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and pharmacological evaluation of thapsigargin analogues for targeting apoptosis to prostatic cancer cells.
Jakobsen CM; Denmeade SR; Isaacs JT; Gady A; Olsen CE; Christensen SB
J Med Chem; 2001 Dec; 44(26):4696-703. PubMed ID: 11741487
[TBL] [Abstract][Full Text] [Related]
32. Elucidation of the topography of the thapsigargin binding site in the sarco-endoplasmic calcium ATPase.
Skytte DM; Møller JV; Liu H; Nielsen HØ; Svenningsen LE; Jensen CM; Olsen CE; Christensen SB
Bioorg Med Chem; 2010 Aug; 18(15):5634-46. PubMed ID: 20615710
[TBL] [Abstract][Full Text] [Related]
33. Side-chain protonation and mobility in the sarcoplasmic reticulum Ca2+-ATPase: implications for proton countertransport and Ca2+ release.
Hauser K; Barth A
Biophys J; 2007 Nov; 93(9):3259-70. PubMed ID: 17938423
[TBL] [Abstract][Full Text] [Related]
34. Distinct natures of beryllium fluoride-bound, aluminum fluoride-bound, and magnesium fluoride-bound stable analogues of an ADP-insensitive phosphoenzyme intermediate of sarcoplasmic reticulum Ca2+-ATPase: changes in catalytic and transport sites during phosphoenzyme hydrolysis.
Danko S; Yamasaki K; Daiho T; Suzuki H
J Biol Chem; 2004 Apr; 279(15):14991-8. PubMed ID: 14754887
[TBL] [Abstract][Full Text] [Related]
35. Paradoxical effects of sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA) activator gingerol on NG115-401L neuronal cells: failure to augment ER Ca(2+) uptake and protect against ER stress-induced cell death.
Zhang C; Bose DD; Thomas DW
Eur J Pharmacol; 2015 Sep; 762():165-73. PubMed ID: 26033206
[TBL] [Abstract][Full Text] [Related]
36. Thapsigargin affinity purification of intracellular P(2A)-type Ca(2+) ATPases.
Vandecaetsbeek I; Christensen SB; Liu H; Van Veldhoven PP; Waelkens E; Eggermont J; Raeymaekers L; Møller JV; Nissen P; Wuytack F; Vangheluwe P
Biochim Biophys Acta; 2011 May; 1813(5):1118-27. PubMed ID: 21215281
[TBL] [Abstract][Full Text] [Related]
37. Ca2+ uptake and release properties of a thapsigargin-insensitive nonmitochondrial Ca2+ store in A7r5 and 16HBE14o- cells.
Missiaen L; Vanoevelen J; Parys JB; Raeymaekers L; De Smedt H; Callewaert G; Erneux C; Wuytack F
J Biol Chem; 2002 Mar; 277(9):6898-902. PubMed ID: 11861657
[TBL] [Abstract][Full Text] [Related]
38. Peptide inhibitors use two related mechanisms to alter the apparent calcium affinity of the sarcoplasmic reticulum calcium pump.
Afara MR; Trieber CA; Ceholski DK; Young HS
Biochemistry; 2008 Sep; 47(36):9522-30. PubMed ID: 18702513
[TBL] [Abstract][Full Text] [Related]
39. 2-Color calcium pump reveals closure of the cytoplasmic headpiece with calcium binding.
Hou Z; Hu Z; Blackwell DJ; Miller TD; Thomas DD; Robia SL
PLoS One; 2012; 7(7):e40369. PubMed ID: 22808146
[TBL] [Abstract][Full Text] [Related]
40. Presence of a thapsigargin-sensitive calcium pump in Trypanosoma evansi: Immunological, physiological, molecular and structural evidences.
Pérez-Gordones MC; Serrano ML; Rojas H; Martínez JC; Uzcanga G; Mendoza M
Exp Parasitol; 2015 Dec; 159():107-17. PubMed ID: 26297682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
